Tag Archives: NASDAQ:AEGR

Thinking about the performance of recent biotech IPOs reminds me of the Black Knight in Monty Python’s Holy Grail: not dead yet.  But even if it’s not dead, its certainly been a very challenging few years for new offerings. In